PMC:7100515 / 15646-15727 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T133","span":{"begin":14,"end":19},"obj":"Body_part"}],"attributes":[{"id":"A133","pred":"fma_id","subj":"T133","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"HEK 293/hACE2 cells were treated with apilimod, a potent inhibitor for PIKfyve35."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T333","span":{"begin":4,"end":7},"obj":"http://purl.obolibrary.org/obo/CLO_0001230"},{"id":"T334","span":{"begin":4,"end":7},"obj":"http://purl.obolibrary.org/obo/CLO_0037237"},{"id":"T335","span":{"begin":4,"end":7},"obj":"http://purl.obolibrary.org/obo/CLO_0050903"},{"id":"T336","span":{"begin":4,"end":7},"obj":"http://purl.obolibrary.org/obo/CLO_0054249"},{"id":"T337","span":{"begin":4,"end":7},"obj":"http://purl.obolibrary.org/obo/CLO_0054250"},{"id":"T338","span":{"begin":4,"end":7},"obj":"http://purl.obolibrary.org/obo/CLO_0054251"},{"id":"T339","span":{"begin":4,"end":7},"obj":"http://purl.obolibrary.org/obo/CLO_0054252"},{"id":"T340","span":{"begin":14,"end":19},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T341","span":{"begin":48,"end":49},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"HEK 293/hACE2 cells were treated with apilimod, a potent inhibitor for PIKfyve35."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T139","span":{"begin":57,"end":66},"obj":"Chemical"}],"attributes":[{"id":"A139","pred":"chebi_id","subj":"T139","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"HEK 293/hACE2 cells were treated with apilimod, a potent inhibitor for PIKfyve35."}

{"project":"LitCovid-sentences","denotations":[{"id":"T118","span":{"begin":0,"end":81},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"HEK 293/hACE2 cells were treated with apilimod, a potent inhibitor for PIKfyve35."}

{"project":"2_test","denotations":[{"id":"32221306-28403145-73894026","span":{"begin":78,"end":80},"obj":"28403145"}],"text":"HEK 293/hACE2 cells were treated with apilimod, a potent inhibitor for PIKfyve35."}

{"project":"LitCovid-PubTator","denotations":[{"id":"715","span":{"begin":8,"end":13},"obj":"Gene"},{"id":"743","span":{"begin":38,"end":46},"obj":"Chemical"},{"id":"752","span":{"begin":0,"end":7},"obj":"CellLine"}],"attributes":[{"id":"A715","pred":"tao:has_database_id","subj":"715","obj":"Gene:59272"},{"id":"A743","pred":"tao:has_database_id","subj":"743","obj":"MESH:C504227"},{"id":"A752","pred":"tao:has_database_id","subj":"752","obj":"CVCL:0045"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"HEK 293/hACE2 cells were treated with apilimod, a potent inhibitor for PIKfyve35."}